Draig Therapeutics
PrivateLast Round
Series A
Jun 18, 2025
Total Funding Raised
$140M
Momentum Score
50 /100
Company Overview
Draig Therapeutics is a biotechnology company that develops a platform designed to deliver treatments for neuropsychiatric disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Draig Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Draig Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 18, 2025 |
Key People
Founding team and executive leadership
Draig Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Health Investors | Series A |
| Intermediate Capital Group | Series A |
| Canaan Partners | Series A |
| Sanofi Ventures | Series A |
| ICG plc | Series A |
| SR One | Series A |
| Schroders Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 25, 2026
Grew 19% QoQ, from 31 to 37 employees.
- Nov 3, 2025
Ivana Magovčević-Liebisch named President and Chief Executive Officer.
Draig Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Draig Therapeutics's valuation, stock price, and market status.
